Cardiovascular Systems, Inc.
CSII · NASDAQ
6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $2 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -8.8% | 9.5% | -4.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 73.1% | 76.4% | 79.4% | 80.8% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -14.2% | -3.9% | -10.1% | 2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -15.6% | -5.2% | -11.5% | -0.1% |
| EPS Diluted | -0.94 | -0.35 | -0.79 | -0.008 |
| % Growth | -168.6% | 55.7% | -10,294.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |